Curaleaf Holdings (CURLF) Capital Leases (2021 - 2025)

Curaleaf Holdings (CURLF) posted quarterly Capital Leases of $144.4 million for Q4 2025, down 4.14% year-on-year from $150.7 million in Q4 2024, and down 4.14% on a QoQ basis from $150.7 million in Q4 2024.

Curaleaf Holdings (CURLF) Capital Leases (2021 - 2025) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Capital Leases for 5 consecutive years, with $144.4 million the latest figure, recorded in Q4 2025.

  • Quarterly Capital Leases fell 4.14% year-over-year to $144.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144.4 million (down 4.14% YoY) and the FY2025 annual result came in at $144.4 million, down 4.14% from the prior year.
  • Capital Leases declined to $144.4 million in Q4 2025 per CURLF's latest filing, from $150.7 million in the prior quarter.
  • Over the last five years, Capital Leases for CURLF reached as high as $167.4 million in Q4 2022 and fell as low as $109.7 million in Q4 2021.
  • A 5-year average of $151.9 million and a median of $154.7 million in 2024 frame the typical range for Capital Leases.
  • Annual changes were most pronounced in 2022 — Capital Leases surged 52.59% — and 2024, when it declined 5.97%.
  • Year by year, Capital Leases stood at $109.7 million in 2021, then jumped by 52.59% to $167.4 million in 2022, then slipped by 4.45% to $160.0 million in 2023, then decreased by 5.8% to $150.7 million in 2024, then slipped by 4.14% to $144.4 million in 2025.
  • According to Business Quant data, Capital Leases over the past three periods registered $144.4 million, $150.7 million, and $153.9 million for Q4 2025, Q4 2024, and Q3 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 144.45 Mn
Dec 31, 2024 150.68 Mn
Sep 30, 2024 153.91 Mn
Jun 30, 2024 154.69 Mn
Dec 31, 2023 159.96 Mn
Sep 30, 2023 162.06 Mn
Jun 30, 2023 164.51 Mn
Dec 31, 2022 167.41 Mn
Dec 31, 2021 109.71 Mn